Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.
about
Human polyomavirus reactivation: disease pathogenesis and treatment approachesMolecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainProgressive multifocal leukoencephalopathy: current treatment options and future perspectivesJC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?Progressive multifocal leukoencephalopathy: clinical and molecular aspectsProgressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.Treatment of Progressive Multifocal Leukoencephalopathy With Mirtazapine.Clinical Trials in Neurovirology: Successes, Challenges, and PitfallsSuppressive effect of PARP-1 inhibitor on JC virus replication in vitro.Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review.Immune reconstitution inflammatory syndrome in a patient with progressive multifocal leukoencephalopathy.Focal neurological disease in patients with acquired immunodeficiency syndrome.Progressive multifocal leukoencephalopathy in HIV-1 infection.Neurologic presentations of AIDS.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerProgressive multifocal leukoencephalopathy in a patient with glioblastoma.Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.Use of cidofovir in progressive multifocal leukoencephalopathy.Update on opportunistic infections in the era of effective antiretroviral therapyMolecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theHexadecyloxypropyl-cidofovir (CMX001) suppresses JC virus replication in human fetal brain SVG cell cultures.JC Virus Leuko-Encephalopathy in Reduced Intensity Conditioning Cord Blood Transplant Recipient with a Review of the Literature.Natalizumab in the treatment of multiple sclerosisCentral nervous system infection during immunosuppression.Polyomavirus nephropathy in kidney transplantation.Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritisManagement of infections by the human polyomavirus JC: past, present and future.Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy.Natalizumab and progressive multifocal leucoencephalopathy.Progressive Multifocal Leukoencephalopathy in a Lung Transplant Recipient: Isolation of John Cunningham (JC) Virus from Bronchoalveolar Lavage.Human immunodeficiency virus-associated progressive multifocal leucoencephalopathy: epidemiology and predictive factors for prolonged survival.Complications of immunosuppressive/immunomodulatory therapy in neurological diseases.Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)An evidence-based review of natalizumab therapy in the management of Crohn's disease.Immune surveillance and response to JC virus infection and PML.Treating multiple sclerosis with monoclonal antibodies: a 2010 update.Progressive multifocal leukoencephalopathy: what's new?Progressive multifocal leukoencephalopathy and natalizumab.
P2860
Q21285083-B5381A04-E2C5-4099-B974-C5FF1EBFE240Q24619923-271B71EF-5D4E-4F7A-BD38-6BDCFBCF14FBQ26776236-AFC73EDA-5F5F-4AC9-998E-008F1531743AQ26852060-569628E7-A5FF-418C-A303-484BB9D3039AQ26858968-82672891-7375-40A7-846F-5E72A44D7F25Q30235523-EF58E85F-EDE2-4022-AD28-97C10BA9DC57Q30245002-FB1673DD-FBDF-401A-B998-2216104BDA6FQ30249052-932E3C20-3015-4B6D-96D6-E3973868B659Q30250271-08AAC5A5-3076-4903-B659-FE535B7BB8C2Q30422440-3EE35D26-49A5-4870-9EE0-73F36BF75CBFQ30778800-5C8DC208-B115-4404-9AB0-8791C4F098E0Q30969485-50AC4268-8F84-4E81-B4CE-1941BB29EE70Q32042586-DE299EFF-C17D-49B3-8BC8-0E91DEBB0B62Q33506561-65D82214-BDA4-4A32-B16A-8A89C0D88F03Q33590337-077C6822-E607-4A44-B765-79122FC0F2C8Q33650105-64FDB51F-4D4E-4E5D-9E95-C658A011ADAFQ33759493-C22A6C03-9BC7-491C-91D1-A618E7DFFC2DQ33893285-AB420DDA-7A32-4883-9D14-7348D8649384Q33951683-334D3E9E-6747-426C-B38F-467269FBB4AFQ34085853-8A2D8D4C-EEEE-4DCF-8BDB-0271D40D54FFQ34110804-7D01CCF1-2D89-4A71-94A8-15D696BBC8C8Q34212799-69333624-721C-4418-82E9-3BCCA7783420Q34290158-07EFE39D-7672-4108-ABCA-6BE27013A5D2Q34343528-5C4BABBA-94DB-4F90-89BA-0D73DF7B85C9Q34409340-220E5522-605F-472E-B2F9-D035F4877EC9Q34469041-83C9FB7B-09FD-4185-8C92-6A6F256A243DQ35841374-12C5654D-ABAD-4B24-BF1C-1DC079A49FCEQ36190565-0BE28462-C234-4716-B5A6-5759100545C0Q36233526-16A5D7E1-E22B-48CD-8A86-4E990192D086Q36234255-9617155D-9FE3-4790-97AE-8D4DCFD64EC3Q36622383-03E2A1EB-02D3-4751-8E3A-74A6E4F9E415Q36671825-8AB87F3F-9935-4F72-92AF-40BB2C28BBECQ36771908-882F1215-62DE-42D4-8290-57B2B7A1F47BQ37013065-D495EF9B-915B-4123-8055-F90B2C04AA3DQ37180338-BC405FB1-FAD9-4D75-BC78-A76F1F39C62AQ37462968-1A6DC9CD-A9F4-4972-AA00-3258971AFDC8Q37678580-67C3597A-94B1-4D3A-A6D5-0BC7C2AFEAB7Q37737305-899C435A-A32D-4801-8892-505AE158AA14Q37755922-83DE390E-3BA6-4406-9F47-A16A8717B818Q37885823-3A87BAA0-1B59-40D7-A161-22AF300CAC7D
P2860
Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Failure of cytarabine in progr ...... linical Trials Group 243 Team.
@ast
Failure of cytarabine in progr ...... linical Trials Group 243 Team.
@en
type
label
Failure of cytarabine in progr ...... linical Trials Group 243 Team.
@ast
Failure of cytarabine in progr ...... linical Trials Group 243 Team.
@en
prefLabel
Failure of cytarabine in progr ...... linical Trials Group 243 Team.
@ast
Failure of cytarabine in progr ...... linical Trials Group 243 Team.
@en
P2093
P1476
Failure of cytarabine in progr ...... Clinical Trials Group 243 Team
@en
P2093
Clifford D
Hollander H
McArthur J
Wetherill PE
P304
P356
10.1056/NEJM199805073381903
P407
P50
P577
1998-05-01T00:00:00Z